Connection

Elizabeth Garrett-Mayer to ErbB Receptors

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about ErbB Receptors.
Elizabeth Garrett-Mayer
Connection Strength
0.218
ErbB Receptors
  1. Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Mol Oncol. 2015 Feb; 9(2):527-43.
    View in: PubMed
    Score: 0.102
  2. Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status. Cancer Causes Control. 2010 Mar; 21(3):399-409.
    View in: PubMed
    Score: 0.073
  3. Stromal cell-derived factor 1a mediates resistance to mTOR-directed therapy in pancreatic cancer. Neoplasia. 2012 Aug; 14(8):690-701.
    View in: PubMed
    Score: 0.022
  4. Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial. Oncology. 2012; 82(2):67-74.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.